At the international congress The Aesthetic MEET 2025 in Austin, Texas, the five-year results from the Motiva U.S. IDE study were recently presented—one of the largest long-term follow-ups of modern breast implants in the United States. The study follows 451 women who underwent primary breast augmentation with Motiva® implants, and the results continue to show an exceptionally low rate of complications.
Let me know if you’d like this adapted further for a specific section—like a news update, patient info, or treatment page.
Summary of Results (5-Year Follow-Up):
-
Capsular Contracture (Baker Grade III/IV): 0.5%
-
Suspected or Confirmed Rupture: 0.6%
-
Breast Pain: 1.2%
-
Infection: 0,9 %
-
Implant Removal (with or without replacement): 3.1%
-
All Reoperations: 8.8%
-
All Complications: 12.0
Dr. Caroline Glicksman, the study’s medical director, emphasized that the results demonstrate remarkable stability over time.
“We’re seeing no increase in capsular contracture or ruptures since we began reporting at the two-year mark. This is a very strong indicator of the implants’ reliability and safety,” she says.
Let me know if you want this quote styled for a press release, blog, or webpage highlight!
FDA Approval for Motiva® in the U.S.
Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round were approved by the FDA in September 2024 for both primary and revision breast augmentation—a major milestone for Establishment Labs and a strong recognition of the implants’ unique safety profile.
What Does This Mean for You as a Patient at Victoriakliniken?
At Victoriakliniken, we work with scientifically proven and innovative techniques designed to deliver natural-looking results with the highest level of safety. Motiva® implants are a key part of our approach—used both in traditional breast surgery and in our unique, minimally invasive methods, Preservé and Mia Femtech. These advanced techniques are designed to preserve more of your body’s natural tissue and support a faster, smoother recovery.
We’re proud to work with implants that demonstrate such strong long-term results—reinforcing our belief that technological innovation leads to better care, safer treatments, and more satisfied patients.
